13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0002010204
Total reported value
$1.2B
$1.2B
20 檔
96.7%
At the close of Q3 2025, BlackBarn Capital Partners LP disclosed equity holdings valued at approximately $1.2B, spread across 20 reported holdings.
In Q3 2025, BlackBarn Capital Partners LP adopted a defensive or profit-taking posture, trimming 9 positions and completely liquidating 9 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 59.60% | +8.54% | — | |
| 2 | RMD | Resmed Inc | Stock-Healthcare | 13.71% | -3.93% | — | |
| 3 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 4.76% | +0.88% | -4.86% | |
| 4 | WRBY | Warby Parker Inc-class A | Stock-Other | 1.97% | -0.68% | — | |
| 5 | PRVA | Privia Health Group Inc | Stock-Other | 1.94% | +0.82% | +45.38% | |
| 6 | DHC | Diversified Healthcare Trust | Stock-Other | 1.94% | +0.63% | -1.60% | |
| 7 | NXT | Nextpower Inc-cl A | Stock-Tech | 1.85% | — | +12.90% | |
| 8 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 1.69% | +4.21% | NEW | |
| 9 | AMRX | Amneal Pharmaceuticals Inc | Stock-Other | 1.57% | +0.25% | -36.47% | |
| 10 | NEE | Nextera Energy Inc | Stock-Utilities | 1.46% | -0.02% | +8.00% | |
| 11 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 1.45% | — | -4.76% | |
| 12 | ACLS | Axcelis Technologies Inc | Stock-Tech | 1.40% | — | -44.44% | |
| 13 | MOH | Molina Healthcare Inc | Stock-Healthcare | 1.30% | — | +26.67% | |
| 14 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 1.08% | — | — | |
| 15 | CCOI | Cogent Communications Holdin | Stock-Other | 1.03% | -1.23% | +56.25% | |
| 16 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 0.94% | +1.17% | +42.86% | |
| 17 | MH | Mcgraw Hill Inc | Stock-Other | 0.76% | -0.34% | — | |
| 18 | ABUS | Arbutus Biopharma CORP | Stock-Other | 0.65% | +0.10% | -23.18% | |
| 19 | FBLA | Fb Bancorp Inc | Stock-Other | 0.54% | — | — | |
| 20 | BVFL | BV Financial Inc | Stock-Other | 0.34% | — | -39.28% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | +15.1% | — | Unchanged |
| 2 | ROIV | Roivant Sciences Ltd. | +1.7% | -4.86% | Trim |
| 3 | DHC | Diversified Healthcare Trust | +1% | -1.60% | Trim |
| 4 | NXT | Nextpower Inc-cl A | +0.9% | +12.90% | Trim |
| 5 | PRVA | Privia Health Group Inc | +0.9% | +45.38% | Add |
| 6 | TEVA | Teva Pharmaceutical-sp Adr | +0.4% | -4.76% | Trim |
| 7 | CCOI | Cogent Communications Holdin | +0.3% | +56.25% | Add |
| 8 | ABUS | Arbutus Biopharma CORP | +0.1% | -23.18% | Trim |
| 9 | FBLA | Fb Bancorp Inc | +0.1% | — | Add |
| 10 | AMRX | Amneal Pharmaceuticals Inc | 0% | -36.47% | Trim |
| 11 | ACLS | Axcelis Technologies Inc | -0.1% | -44.44% | Trim |
| 12 | BVFL | BV Financial Inc | -0.1% | -39.28% | Trim |
| 13 | MOH | Molina Healthcare Inc | -0.7% | +26.67% | Trim |
| 14 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | — | EXIT | Sold out |
| 15 | RMD | Resmed Inc | — | NEW | New buy |
| 16 | TSLA | Tesla Inc | — | EXIT | Sold out |
| 17 | UNH | Unitedhealth Group Inc | — | EXIT | Sold out |
| 18 | WRBY | Warby Parker Inc-class A | — | NEW | New buy |
| 19 | OSCR | Oscar Health Inc - Class A | — | NEW | New buy |
| 20 | NEE | Nextera Energy Inc | — | NEW | New buy |
| 21 | WBA | Walgreens Boots Alliance Inc | — | EXIT | Sold out |
| 22 | ELAN | Elanco Animal Health Inc | — | NEW | New buy |
| 23 | BRBS | Blue Ridge Bankshares Inc | — | EXIT | Sold out |
| 24 | VKTX | Viking Therapeutics Inc | — | NEW | New buy |
| 25 | MH | Mcgraw Hill Inc | — | NEW | New buy |
| 26 | EGBN | Eagle Bancorp Inc | — | EXIT | Sold out |
| 27 | RH | Rh | — | EXIT | Sold out |
| 28 | HBNC | Horizon Bancorp Inc/in | — | EXIT | Sold out |
| 29 | MODVQ | Modivcare Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, BlackBarn Capital Partners LP reported a total U.S. public equity portfolio value of $1.2B across 20 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, RMD, ROIV) accounted for 96.7% of total reported equity market value during Q3 2025.
Top New Position Initiated
RMD
市值: $191.6M
Top Position Liquidated / Trimmed
HYG
前期市值: $433.9M
During Q3 2025, BlackBarn Capital Partners LP's top holdings by market value included SPY (59.6%)、RMD (13.7%)、ROIV (4.8%). The largest single position, SPY, represented 59.6% of total portfolio value.
In Q3 2025, BlackBarn Capital Partners LP made 28 total portfolio adjustments, initiating 7 new buys, adding to 3 positions, trimming 9 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.